With the 4th approval on CAR-T therapy (Breyanzi) by FDA in early 2021, ex vivo engineered T cell therapy was proved as a mainstay in cancer treatment.

Antibodies are crucial tools in scientific research and in recent years, act as diagnostic tool and a therapeutic mean to many diseases.

High-Quality Plasmid DNA Manufacturing Strategies for Advanced Therapeutic Products